The authors summarized recent data on selected immune checkpoints of the immunoglobulin superfamily and the tumor necrosis factor receptor superfamily that have a documented role in the regulation of leukemia stem cells, independent of their immune regulatory role, and might become novel therapeutic targets.
[Leukemia]
